Comparative analysis of cell therapy infusion workflows at clinical sites

Vismara, 2017, Current Options for Cell Therapy in Spinal Cord Injury, Trends Mol Med, 23, 831, 10.1016/j.molmed.2017.07.005 Duncan, 2017, Alzheimer's disease, dementia, and stem cell therapy, Stem Cell Res Ther, 8, 111, 10.1186/s13287-017-0567-5 Strom, 2019, Cell Therapy of Liver Disease: From Hepatocytes to Stem Cells, 229 Kahlon, 2018, Cell therapy for heart disease: current status and future directions, Minerva Cardioangiol, 66, 273 Műzes, 2019, Issues and opportunities of stem cell therapy in autoimmune diseases, World J Stem Cells, 11, 212, 10.4252/wjsc.v11.i4.212 Kunk, 2016, From bench to bedside a comprehensive review of pancreatic cancer immunotherapy, J Immunother Cancer, 4, 14, 10.1186/s40425-016-0119-z Rezvani, 2019, Adoptive cell therapy using engineered natural killer cells, Bone Marrow Transplant, 54, 785, 10.1038/s41409-019-0601-6 Brunstein, 2016, Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect, Blood, 127, 1044, 10.1182/blood-2015-06-653667 Matthay, 2010, Therapeutic Potential of Mesenchymal Stem Cells for Severe Acute Lung Injury, Chest, 138, 965, 10.1378/chest.10-0518 Koepsell, 2013, Natural killer cells: a review of manufacturing and clinical utility, Transfusion, 53, 404, 10.1111/j.1537-2995.2012.03724.x Tang, 2018, The global landscape of cancer cell therapy, Nature Reviews Drug Discovery, 17, 465, 10.1038/nrd.2018.74 Yu, 2020, Cancer cell therapies: the clinical trial landscape, Nature Reviews Drug Discovery, 19, 583, 10.1038/d41573-020-00099-9 Alliance for Regenerative Medicine. ARM's Q3 2020 Trend Talk. 2020. http://alliancerm.org/wp-content/uploads/2020/11/Q3-Report-Print-Version.pdf. Accessed June 1, 2020. US Food and Drug Administration C for BE and R. Approved Cellular and Gene Therapy Products. 2020. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products. Accessed December 7, 2020. Paul-Ehrlich-Institut FI for V and B. Gene Therapy Medicinal Products with a valid marketing authorisation. 2020. https://www.pei.de/EN/medicinal-products/atmp/gene-therapy-medicinal-products/gene-therapy-node.html. Accessed December 7, 2020. Levine, 2017, Global Manufacturing of CAR T Cell Therapy, Mol Ther Methods Clin Dev, 4, 92, 10.1016/j.omtm.2016.12.006 Wang, 2016, Clinical manufacturing of CAR T cells: foundation of a promising therapy, Mol Ther Oncolytics, 3, 16015, 10.1038/mto.2016.15 Gniadek, 2018, Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study, Transfusion, 58, 461, 10.1111/trf.14429 Hubel, 2018 Li, 2019, Preservation of cell-based immunotherapies for clinical trials, Cytotherapy, 21, 943, 10.1016/j.jcyt.2019.07.004 Worsham, 2017, Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations, Transfusion, 57, 1555, 10.1111/trf.14112 American Association of Blood Banks. Standards Programs. AABB. 2018. http://www.aabb.org/sa/standards/Pages/standards-programs.aspx. Accessed April 6, 2020. 2020 Cain, 2008, Chapter 31 Organizational Workflow and Its Impact on Work Quality, 217 Food and Drug Administration. Prescribing information - Kymriah. 2018. https://www.fda.gov/media/107296/download. Accessed April 6, 2020. Wuchter, 2019, Processing, cryopreserving, and controlling the quality of HSCs, 128 2016 2019 2019 Winacoo, 2019, Implementing Immune Effector Cell Education for Nursing Staff, Biol Blood Marrow Transplant, 25, S439, 10.1016/j.bbmt.2018.12.476 Benedetti, 2019, Developing BMT Nurses to Care for Axicabtagene Ciloleucel (Yescarta) Chimeric Antigen Receptor T Cell Patients, Biol Blood Marrow Transplant, 25, S438, 10.1016/j.bbmt.2018.12.474 Hankewycz, 2019, Evaluating Nursing Readiness and Competency for Direct Patient Care after Initiation of New Pediatric CAR-T Cell Therapy Program, Biol Blood Marrow Transplant, 25, S82, 10.1016/j.bbmt.2018.12.188 Hutnick, 2019, Shifting Gears from Transplant to CAR T: Creating a Cell Therapy Nurse Coordinator Role, Biol Blood Marrow Transplant, 25, S82, 10.1016/j.bbmt.2018.12.186 Keever-Taylor, 2015, Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation, Cytotherapy, 17, 1831, 10.1016/j.jcyt.2015.08.006 Dave, 2019, Driving the CAR to the Bone Marrow Transplant Program, Curr Hematol Malig Rep, 14, 561, 10.1007/s11899-019-00544-6 Perica, 2018, Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center, Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 24, 1135, 10.1016/j.bbmt.2018.02.018 2017 2021 2012 Nuttall, 2013, Computerized bar code-based blood identification systems and near-miss transfusion episodes and transfusion errors, Mayo Clin Proc, 88, 354, 10.1016/j.mayocp.2012.12.010 Murphy, 2020, Establishing a Satellite Transfusion Service Within an Academic Medical Center, Am J Clin Pathol, 153, 842, 10.1093/ajcp/aqaa018 Algora, 2018, Challenges in Establishing a Transfusion Medicine Service: The Cleveland Clinic Abu Dhabi Experience, Arch Pathol Lab Med, 142, 1233, 10.5858/arpa.2017-0513-OA 2020 2018